TY  - GEN
AU  - Zhang,Panpan
AU  - Gong,Yiyi
AU  - Liu,Zheng
AU  - Liu,Yanying
AU  - Lin,Wei
AU  - Li,Jieqiong
AU  - Wang,Mu
AU  - Liu,Xiaowei
AU  - Fei,Yunyun
AU  - Chen,Hua
AU  - Peng,Linyi
AU  - Li,Jing
AU  - Zhou,Jiaxin
AU  - Shi,Qun
AU  - Zhang,Xuan
AU  - Shen,Min
AU  - Zeng,Xiaofeng
AU  - Zhang,Fengchun
AU  - Li,Yongzhe
AU  - Zhao,Yan
AU  - Zhang,Wen
TI  - Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial
SN  - 1756-185X
PY  - 2020///0129
KW  - Adrenal Cortex Hormones
KW  - adverse effects
KW  - Adult
KW  - Autoimmunity
KW  - drug effects
KW  - Betamethasone
KW  - analogs & derivatives
KW  - Biomarkers
KW  - blood
KW  - China
KW  - Chromones
KW  - Drug Combinations
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Immunoglobulin G4-Related Disease
KW  - Immunosuppressive Agents
KW  - Male
KW  - Metabolome
KW  - Middle Aged
KW  - Prospective Studies
KW  - Remission Induction
KW  - Severity of Illness Index
KW  - Sulfonamides
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1111/1756-185X.13633
ER  -